October 5 - 6, Virtual Meeting
Cancer initiation and progression involves complex processes that cannot be modelled completely using conventional 2D cultures of tumour cells. Integrated multidisciplinary efforts have led to the development of a wide range of novel approaches involving 3D culture, organoids, bioengineered systems, and in vivo models that more accurately reflect the biochemical, spatial and mechanical properties of tumours in their tissue environment. This virtual conference is organized by the EACR and will focus on the next generation of cancer models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, intravital imaging and high-content analysis for cancer therapeutics.
Who should attend?
- Faculty, postdocs, and graduate students interested in the techniques and applications of next-generation cancer models at the intersection of cancer biology, engineering, and drug development.
- Industry scientists interested in identifying promising platforms for drug discovery and targets for novel therapies.
Topics to be covered
- Cell adhesion, mechanics, migration and survival
- Imaging cancer invasion in 3D culture and in vivo
- 3D in vitro systems for drug development and clinical applications
- Intercellular interactions and the immune microenvironment
MIMETAS is proud to be part of this conference by having our Director of Model Development, Henriette Lanz in the Scientific Programme Committee. For more information about the program and registration, please follow the link below.